153 related articles for article (PubMed ID: 33165878)
1. ANCA-associated vasculitis patients treated in Polish intensive care units - retrospective characteristics based on the POLVAS registry.
Włudarczyk A; Biedroń G; Wójcik K; Zdrojewski Z; Masiak A; Czuszyńska Z; Majdan M; Jeleniewicz R; Krajewska M; Kusztal M; Brzosko M; Brzosko I; Dębska-Ślizień A; Storoniak H; Tłustochowicz W; Kur-Zalewska J; Rydzewski A; Madej M; Hawrot-Kawecka A; Stasiek M; Kucharz E; Musial J; Szczeklik W
Anaesthesiol Intensive Ther; 2020; 52(4):281-286. PubMed ID: 33165878
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of Polish patients with ANCA-associated vasculitides-retrospective analysis of POLVAS registry.
Wójcik K; Wawrzycka-Adamczyk K; Włudarczyk A; Sznajd J; Zdrojewski Z; Masiak A; Czuszyńska Z; Majdan M; Jeleniewicz R; Klinger M; Jakuszko K; Rowaiye O; Brzosko M; Milchert M; Dębska-Ślizień A; Storoniak H; Tłustochowicz W; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz E; Musiał J
Clin Rheumatol; 2019 Sep; 38(9):2553-2563. PubMed ID: 31016580
[TBL] [Abstract][Full Text] [Related]
3. Value of prognostic scores in antineutrophil cytoplasmic antibody (ANCA) associated vasculitis patients in intensive care unit: a multicenter retrospective cohort study from Turkey.
Özdemir U; Ortaç Ersoy E; Yüksel RC; Kaya E; Aygencel G; Türkoğlu M; Topeli A; Güven M; Sungur M; Altintaş ND
Turk J Med Sci; 2020 Aug; 50(5):1223-1230. PubMed ID: 32304194
[TBL] [Abstract][Full Text] [Related]
4. Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series.
Monti S; Montecucco C; Pieropan S; Mojoli F; Braschi A; Caporali R
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-126-31. PubMed ID: 26016763
[TBL] [Abstract][Full Text] [Related]
5. Treatment and its side effects in ANCA-associated vasculitides - Study based on POLVAS registry data.
Biedroń G; Włudarczyk A; Wawrzycka-Adamczyk K; Wójcik K; Sznajd J; Zdrojewski Z; Masiak A; Czuszyńska Z; Majdan M; Jeleniewicz R; Klinger M; Jakuszko K; Rowaiye OO; Brzosko M; Brzosko I; Dębska-Ślizień A; Storoniak H; Tłustochowicz W; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ; Musiał J; Szczeklik W
Adv Med Sci; 2020 Mar; 65(1):156-162. PubMed ID: 31958704
[TBL] [Abstract][Full Text] [Related]
6. Respiratory involvement in antineutrophil cytoplasmic antibody-associated vasculitides: a retrospective study based on POLVAS registry.
Biedroń G; Włudarczyk A; Wawrzycka-Adamczyk K; Wójcik K; Musiał J; Bazan-Socha S; Zdrojewski Z; Masiak A; Czuszyńska Z; Majdan M; Jeleniewicz R; Klinger M; Krajewska M; Augustyniak-Bartosik H; Jakuszko K; Brzosko M; Brzosko I; Dębska-Ślizień A; Storoniak H; Bułło-Piontecka B; Tłustochowicz W; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ; Szczeklik W
Clin Exp Rheumatol; 2022 May; 40(4):720-726. PubMed ID: 35485410
[TBL] [Abstract][Full Text] [Related]
7. Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study.
Demiselle J; Auchabie J; Beloncle F; Gatault P; Grangé S; Du Cheyron D; Dellamonica J; Boyer S; Beauport DT; Piquilloud L; Letheulle J; Guitton C; Chudeau N; Geri G; Fourrier F; Robert R; Guérot E; Boisramé-Helms J; Galichon P; Dequin PF; Lautrette A; Bollaert PE; Meziani F; Guillevin L; Lerolle N; Augusto JF
Ann Intensive Care; 2017 Dec; 7(1):39. PubMed ID: 28382598
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
[TBL] [Abstract][Full Text] [Related]
9. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 33309337
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
11. Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes.
Katikineni VS; Kant S; Gapud EJ; Antiochos B; Manno RL; Phillips M; Seo P; Geetha D
Clin Rheumatol; 2019 Aug; 38(8):2195-2199. PubMed ID: 31037456
[TBL] [Abstract][Full Text] [Related]
12. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
[TBL] [Abstract][Full Text] [Related]
13. [High burden of disease in patients with ANCA-associated vasculitis : A claims data study in Germany].
Haller HG; von Vietinghoff S; Spearpoint P; Deichmann A; Buchholz I; Schönermark MP; Rutherford P; Götte D
Internist (Berl); 2022 Feb; 63(2):210-216. PubMed ID: 34665272
[TBL] [Abstract][Full Text] [Related]
14. Patients with small-vessel vasculitides have the highest mortality among systemic autoimmune diseases patients treated in intensive care unit: A retrospective study with 5-year follow-up.
Włudarczyk A; Polok K; Górka J; Hałek A; Biedroń G; Krawczyk P; Musiał J; Szczeklik W
J Crit Care; 2018 Dec; 48():166-171. PubMed ID: 30216934
[TBL] [Abstract][Full Text] [Related]
15. [Off-label biologic therapy of ANCA-associated and non-ANCA-associated small-vessel vasculitis : Efficacy and safety analysis of a national registry (GRAID2)].
Venhoff N; Proft F; Schulze-Koops H; Holle J; Voll RE; Iking-Konert C; Jacobi AM; Henes J; Unger L; Kneitz O; Dörner T; Thiel J
Z Rheumatol; 2018 Feb; 77(1):21-27. PubMed ID: 28508096
[TBL] [Abstract][Full Text] [Related]
16. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 36165341
[TBL] [Abstract][Full Text] [Related]
17. Patients With Vasculitides Admitted to the Intensive Care Unit: Implications From a Single-Center Retrospective Study.
Haviv Y; Shovman O; Bragazzi NL; Sharif K; Yavne Y; Shoenfeld Y; Amital H; Watad A
J Intensive Care Med; 2019 Oct; 34(10):828-834. PubMed ID: 28662606
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study.
Sacri AS; Chambaraud T; Ranchin B; Florkin B; Sée H; Decramer S; Flodrops H; Ulinski T; Allain-Launay E; Boyer O; Dunand O; Fischbach M; Hachulla E; Pietrement C; Le Pogamp P; Stephan JL; Belot A; Nivet H; Nobili F; Guillevin L; Quartier P; Deschênes G; Salomon R; Essig M; Harambat J
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i104-12. PubMed ID: 25676121
[TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement.
Chu X; Hong Y; Wang Y; Yu C; Wang L; Tong H; Yan J; Zhang Z; Xu G; Yao Y; Zeng R
Am J Nephrol; 2021; 52(12):899-908. PubMed ID: 34875652
[TBL] [Abstract][Full Text] [Related]
20. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
